April 3, 2019

Results From Combination of APR-246 with Immuno-Oncology Agents Presented at the 2019 American Association for Cancer Research (AACR) Annual Meeting in Atlanta

Studies support synergistic role of p53 stabilization by APR-246 in combination with immuno-oncology agents BOSTON, MA. and STOCKHOLM, SWEDEN, April 3, 2019 – Aprea Therapeuti...
Read more
April 2, 2019

MIPS continues to be confident about its leading technology

Non-regulatory / April 2, 2019  Following the previous communication in relation to bike gear company Bontrager’s new helmets equipped with a new helmet technology ca...
Read more
April 2, 2019

Nordic Nanovector: Promising results from preclinical studies with a novel CD37-targeted alpha therapy for B-cell tumours presented at TAT11

02.04.2019 07:00 Oslo, Norway, 2 April 2019 Nordic Nanovector ASA (OSE: NANO) notes that promising results from its preclinical research collaboration to develop a no...
Read more
April 1, 2019

Fusion Pharmaceuticals Raises $105 Million In Oversubscribed Series B Financing

Lead investors Varian and OrbiMed, are joined by Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital and all existing investors Funding to Accelerate the ...
Read more
April 1, 2019

Altimmune Announces Financial Results for the Year Ended December 31, 2018 and Provides Corporate Update

Conference call and webcast scheduled for Tuesday, April 2, at 8:30 am Eastern Time GAITHERSBURG, Md., April 01, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clin...
Read more
March 29, 2019

District Court of Delaware rules that Actavis does not infringes with their Suboxone® and Subutex® generics

Uppsala, Sweden - March 29, 2019 – Orexo AB (publ.), the fully integrated specialty pharmaceutical company, with strong long-term patent protection (no. 8,940,330) for its...
Read more
March 29, 2019

MIPS AB today publishes the 2018 Annual Report

March 29, 2019 MIPS AB (publ) today publishes the annual report for 2018. The annual report is available on the company’s website, www.mipscorp.com — This i...
Read more
March 25, 2019

Strongbridge Biopharma plc Announces Presentation of New Data Analyses from Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome

~ Subgroup Analysis of Patients with Comorbid Diabetes Mellitus and Cushing’s Syndrome Presented at Annual Meeting of the Endocrine Society (ENDO) Shows Potential Clin...
Read more
March 21, 2019

MIPS unable to replicate new WaveCel helmet technology performance claims

STOCKHOLM, SWEDEN — MARCH 21, 2019 As the leader in the field of rotational motion solutions for helmets, MIPS subjected the new WaveCel helmet technology to...
Read more
March 21, 2019

Orexo publishes the Annual Report for 2018

Uppsala, Sweden - March 21, 2019 – Orexo’s Annual Report, including the Sustainability Report, for the 2018 fiscal year has been published and can be downloaded on the com...
Read more